Intestinal myofibroblasts and immune tolerance

J. I. Saada, C. A. Barrera, Victor Reyes, P. A. Adegboyega, G. Suarez, R. A. Tamerisa, K. F. Pang, D. A. Bland, R. C. Mifflin, J. F. Di Mari, D. W. Powell

Research output: Contribution to journalArticle

14 Citations (Scopus)

Abstract

Stromal cells, such as myofibroblasts and fibroblasts, represent a significant fraction of MHC class II-positive cells in the normal human colonic lamina propria, suggesting they may play an important role in CD4+ T cell regulation in a tolerogenic environment. The aim of this study was to examine whether human colonic myofibroblasts (CMFs) phenotypically and functionally resemble conventional antigen-presenting cells (APCs). Our results support the hypothesis that intestinal myofibroblasts are a novel, nonprofessional APC phenotype important in modulating mucosal T cell responses. Given their strategic location, we propose that intestinal myofibroblasts play a critical role in mediating tolerance to luminal antigens.

Original languageEnglish (US)
Pages (from-to)379-381
Number of pages3
JournalAnnals of the New York Academy of Sciences
Volume1029
DOIs
StatePublished - 2004

Fingerprint

Immune Tolerance
Myofibroblasts
T-cells
Antigen-Presenting Cells
Fibroblasts
Cells
T-Lymphocytes
Antigens
Stromal Cells
Mucous Membrane
Phenotype
Tolerance

Keywords

  • Antigen-presenting cell
  • Fibroblastic sheath
  • HLA-DR
  • Immune tolerance
  • Mucosal immunity

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Saada, J. I., Barrera, C. A., Reyes, V., Adegboyega, P. A., Suarez, G., Tamerisa, R. A., ... Powell, D. W. (2004). Intestinal myofibroblasts and immune tolerance. Annals of the New York Academy of Sciences, 1029, 379-381. https://doi.org/10.1196/annals.1309.023

Intestinal myofibroblasts and immune tolerance. / Saada, J. I.; Barrera, C. A.; Reyes, Victor; Adegboyega, P. A.; Suarez, G.; Tamerisa, R. A.; Pang, K. F.; Bland, D. A.; Mifflin, R. C.; Di Mari, J. F.; Powell, D. W.

In: Annals of the New York Academy of Sciences, Vol. 1029, 2004, p. 379-381.

Research output: Contribution to journalArticle

Saada, JI, Barrera, CA, Reyes, V, Adegboyega, PA, Suarez, G, Tamerisa, RA, Pang, KF, Bland, DA, Mifflin, RC, Di Mari, JF & Powell, DW 2004, 'Intestinal myofibroblasts and immune tolerance', Annals of the New York Academy of Sciences, vol. 1029, pp. 379-381. https://doi.org/10.1196/annals.1309.023
Saada, J. I. ; Barrera, C. A. ; Reyes, Victor ; Adegboyega, P. A. ; Suarez, G. ; Tamerisa, R. A. ; Pang, K. F. ; Bland, D. A. ; Mifflin, R. C. ; Di Mari, J. F. ; Powell, D. W. / Intestinal myofibroblasts and immune tolerance. In: Annals of the New York Academy of Sciences. 2004 ; Vol. 1029. pp. 379-381.
@article{3a8a8448ce68416aaaa800d30ad18e71,
title = "Intestinal myofibroblasts and immune tolerance",
abstract = "Stromal cells, such as myofibroblasts and fibroblasts, represent a significant fraction of MHC class II-positive cells in the normal human colonic lamina propria, suggesting they may play an important role in CD4+ T cell regulation in a tolerogenic environment. The aim of this study was to examine whether human colonic myofibroblasts (CMFs) phenotypically and functionally resemble conventional antigen-presenting cells (APCs). Our results support the hypothesis that intestinal myofibroblasts are a novel, nonprofessional APC phenotype important in modulating mucosal T cell responses. Given their strategic location, we propose that intestinal myofibroblasts play a critical role in mediating tolerance to luminal antigens.",
keywords = "Antigen-presenting cell, Fibroblastic sheath, HLA-DR, Immune tolerance, Mucosal immunity",
author = "Saada, {J. I.} and Barrera, {C. A.} and Victor Reyes and Adegboyega, {P. A.} and G. Suarez and Tamerisa, {R. A.} and Pang, {K. F.} and Bland, {D. A.} and Mifflin, {R. C.} and {Di Mari}, {J. F.} and Powell, {D. W.}",
year = "2004",
doi = "10.1196/annals.1309.023",
language = "English (US)",
volume = "1029",
pages = "379--381",
journal = "Annals of the New York Academy of Sciences",
issn = "0077-8923",
publisher = "Wiley-Blackwell",

}

TY - JOUR

T1 - Intestinal myofibroblasts and immune tolerance

AU - Saada, J. I.

AU - Barrera, C. A.

AU - Reyes, Victor

AU - Adegboyega, P. A.

AU - Suarez, G.

AU - Tamerisa, R. A.

AU - Pang, K. F.

AU - Bland, D. A.

AU - Mifflin, R. C.

AU - Di Mari, J. F.

AU - Powell, D. W.

PY - 2004

Y1 - 2004

N2 - Stromal cells, such as myofibroblasts and fibroblasts, represent a significant fraction of MHC class II-positive cells in the normal human colonic lamina propria, suggesting they may play an important role in CD4+ T cell regulation in a tolerogenic environment. The aim of this study was to examine whether human colonic myofibroblasts (CMFs) phenotypically and functionally resemble conventional antigen-presenting cells (APCs). Our results support the hypothesis that intestinal myofibroblasts are a novel, nonprofessional APC phenotype important in modulating mucosal T cell responses. Given their strategic location, we propose that intestinal myofibroblasts play a critical role in mediating tolerance to luminal antigens.

AB - Stromal cells, such as myofibroblasts and fibroblasts, represent a significant fraction of MHC class II-positive cells in the normal human colonic lamina propria, suggesting they may play an important role in CD4+ T cell regulation in a tolerogenic environment. The aim of this study was to examine whether human colonic myofibroblasts (CMFs) phenotypically and functionally resemble conventional antigen-presenting cells (APCs). Our results support the hypothesis that intestinal myofibroblasts are a novel, nonprofessional APC phenotype important in modulating mucosal T cell responses. Given their strategic location, we propose that intestinal myofibroblasts play a critical role in mediating tolerance to luminal antigens.

KW - Antigen-presenting cell

KW - Fibroblastic sheath

KW - HLA-DR

KW - Immune tolerance

KW - Mucosal immunity

UR - http://www.scopus.com/inward/record.url?scp=20044383918&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=20044383918&partnerID=8YFLogxK

U2 - 10.1196/annals.1309.023

DO - 10.1196/annals.1309.023

M3 - Article

C2 - 15681786

AN - SCOPUS:20044383918

VL - 1029

SP - 379

EP - 381

JO - Annals of the New York Academy of Sciences

JF - Annals of the New York Academy of Sciences

SN - 0077-8923

ER -